Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial

被引:23
|
作者
Sarraj, Amrou [1 ,3 ]
Abraham, Michael G. [5 ]
Hassan, Ameer E. [6 ]
Blackburn, Spiros [7 ]
Kasner, Scott E. [10 ]
Ortega-Gutierrez, Santiago [11 ]
Hussain, Muhammad Shazam [12 ]
Chen, Michael [13 ]
Johns, Hannah [14 ]
Churilov, Leonid [14 ]
Pujara, Deep K. [1 ,3 ]
Shaker, Faris [7 ]
Maali, Laith [5 ]
Portela, Pere Cardona [15 ]
Herial, Nabeel A. [16 ]
Gibson, Daniel [17 ]
Kozak, Osman [18 ]
Arenillas, Juan F. [19 ]
Yan, Bernard [14 ,20 ]
de la Ossa, Natalia Perez [21 ]
Sundararajan, Sophia [1 ,3 ]
Hu, Yin C. [2 ,4 ]
Cordato, Dennis J. [22 ,27 ]
Manning, Nathan W. [23 ]
Hanel, Ricardo A. [24 ]
Aghaebrahim, Amin N. [24 ]
Budzik, Ronald F. [25 ]
Hicks, William J. [26 ]
Blasco, Jordi [27 ]
Wu, Teddy Y. [28 ]
Tsai, Jenny P. [12 ]
Schaafsma, Joanna D. [29 ]
Gandhi, Chirag D. [30 ]
Al-Mufti, Fawaz [30 ]
Sangha, Navdeep [31 ]
Warach, Steven [32 ]
Kleinig, Timothy J. [33 ]
Yogendrakumar, Vignan [20 ]
Ng, Felix [20 ]
Samaniego, Edgar A. [11 ]
Abdulrazzak, Mohammad A. [12 ]
Parsons, Mark W. [22 ]
Rahbar, Mohammad H. [8 ]
Nguyen, Thanh N. [34 ]
Fifi, Johanna T. [35 ]
Pereira, Vitor Mendes [36 ]
Lansberg, Maarten G. [37 ]
Albers, Greg W. [37 ]
Furlan, Anthony J. [1 ,3 ]
Jabbour, Pascal [16 ]
机构
[1] Univ Hosp Cleveland Med Ctr, Dept Neurol, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland Med Ctr, Dept Neurosurg, Cleveland, OH USA
[3] Case Western Reserve Univ, Dept Neurol, Cleveland, OH USA
[4] Case Western Reserve Univ, Dept Neurosurg, Cleveland, OH USA
[5] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS USA
[6] Valley Baptist Med Ctr, Dept Neurosci, Harlingen, TX USA
[7] McGovern Med Sch UTHealth, Dept Neurosurg, Houston, TX USA
[8] UTHlth, Dept Internal Med, McGovern Med Sch, Houston, TX USA
[9] UTHlth, Dept Intervent & Diagnost Imaging, McGovern Med Sch, Houston, TX USA
[10] Univ Penn, Dept Neurol, Philadelphia, PA USA
[11] Univ Iowa Hosp & Clin, Dept Neurosurg & Radiol, Iowa City, IA USA
[12] Cleveland Clin, Cerebrovasc Ctr, Cleveland, OH USA
[13] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL USA
[14] Univ Melbourne, Dept Med & Neurol, Parkville, Vic, Australia
[15] Hosp Univ Bellvitge, Dept Neurol, Bellvitge, Spain
[16] Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA USA
[17] Ascension Wisconsin, Dept Neurosurg, Indianapolis, IN USA
[18] Abington Jefferson Hlth, Dept Neurosurg, Abington, PA USA
[19] Univ Valladolid, Hosp Clin Univ Valladolid, Dept Internal Med, Valladolid, Spain
[20] Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Internal Med & Neurol, Parkville, Vic, Australia
[21] Hosp Univ Germans Trias i Pujol, Dept Neurol, Barcelona, Spain
[22] Liverpool Hosp, Dept Neurol, Liverpool, NSW, Australia
[23] Ingham Inst, Dept Neurosurg, Liverpool, NSW, Australia
[24] Baptist Med Ctr Jacksonville, Dept Neurosurg, Jacksonville, FL USA
[25] OhioHlth Riverside Methodist Hosp, Dept Neurointervent Radiol, Columbus, OH USA
[26] OhioHlth Riverside Methodist Hosp, Dept Neurol, Columbus, OH USA
[27] Hosp Clin Barcelona, Dept Intervent Radiol, Barcelona, Spain
[28] Christchurch Hosp, Dept Neurol, Christchurch, New Zealand
[29] Toronto Western Hosp, Dept Internal Med, Toronto, ON, Canada
[30] NY Med Coll, Westchester Med Ctr, Dept Neurosurg, Valhalla, NY USA
[31] Kaiser Permanente Southern Calif, Dept Neurol, Los Angeles, CA USA
[32] Univ Texas Austin Ascension Texas, Dell Med Sch, Dept Neurol, Austin, TX USA
[33] Royal Adelaide Hosp, Dept Neurol, Adelaide, SA, Australia
[34] Boston Med Ctr, Dept Neurol, Boston, MA USA
[35] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY USA
[36] St Michaels Hosp, Dept Neurol, Toronto, ON, Canada
[37] Stanford Univ, Dept Neurol, Stanford, CA USA
[38] Univ Pittsburgh, Med Ctr, Dept Neurol, Pittsburgh, PA USA
[39] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[40] Mem Hermann Hosp, Mobile Stroke Unit, Houston, TX USA
[41] Hosp Valle De Hebron, Dept Neurol, Barcelona, Spain
[42] Florey Inst Neurosci & Mental Hlth, Dept Med & Neurol, Parkville, Vic, Australia
来源
LANCET | 2024年 / 403卷 / 10428期
关键词
HUMAN BRAIN;
D O I
10.1016/S0140-6736(24)00050-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Multiple randomised trials have shown efficacy and safety of endovascular thrombectomy in patients with large ischaemic stroke. The aim of this study was to evaluate long-term (ie, at 1 year) evidence of benefit of thrombectomy for these patients. Methods SELECT2 was a phase 3, open-label, international, randomised controlled trial with blinded endpoint assessment, conducted at 31 hospitals in the USA, Canada, Spain, Switzerland, Australia, and New Zealand. Patients aged 18-85 years with ischaemic stroke due to proximal occlusion of the internal carotid artery or of the first segment of the middle cerebral artery, showing large ischaemic core on non-contrast CT (Alberta Stroke Program Early Computed Tomographic Score of 3-5 [range 0-10, with lower values indicating larger infarctions]) or measuring 50 mL or more on CT perfusion and MRI, were randomly assigned, within 24 h of ischaemic stroke onset, to thrombectomy plus medical care or to medical care alone. The primary outcome for this analysis was the ordinal modified Rankin Scale (range 0-6, with higher scores indicating greater disability) at 1-year follow-up in an intention-to-treat population. The trial is registered at ClinicalTrials.gov (NCT03876457) and is completed. Findings The trial was terminated early for efficacy at the 90-day follow-up after 352 patients had been randomly assigned (178 to thrombectomy and 174 to medical care only) between Oct 11, 2019, and Sept 9, 2022. Thrombectomy significantly improved the 1-year modified Rankin Scale score distribution versus medical care alone (WilcoxonMann-Whitney probability of superiority 0<middle dot>59 [95% CI 0<middle dot>53-0<middle dot>64]; p=0<middle dot>0019; generalised odds ratio 1<middle dot>43 [95% CI 1<middle dot>14-1<middle dot>78]). At the 1-year follow-up, 77 (45%) of 170 patients receiving thrombectomy had died, compared with 83 (52%) of 159 patients receiving medical care only (1-year mortality relative risk 0<middle dot>89 [95% CI 0<middle dot>71-1<middle dot>11]). Interpretation In patients with ischaemic stroke due to a proximal occlusion and large core, thrombectomy plus medical care provided a significant functional outcome benefit compared with medical care alone at 1-year follow-up. Funding Stryker Neurovascular. Copyright (c) 2024 Elsevier Ltd. All rights reserved.
引用
收藏
页码:731 / 740
页数:10
相关论文
共 32 条
  • [32] Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial
    Lariviere, Ynke
    Matuvanga, Tresor Zola
    Osang'ir, Bernard Isekah
    Milolo, Solange
    Meta, Rachel
    Kimbulu, Primo
    Robinson, Cynthia
    Katwere, Michael
    McLean, Chelsea
    Lemey, Gwen
    Matangila, Junior
    Maketa, Vivi
    Mitashi, Patrick
    Van Geertruyden, Jean-Pierre
    Van Damme, Pierre
    Muhindo-Mavoko, Hypolite
    LANCET INFECTIOUS DISEASES, 2024, 24 (07): : 746 - 759